LP65523-0
Everolimus
Active
Description
Everolimus is a kinase inhibitor that is used to treat a number of cancers and to prevent rejection of organ transplants. It is an mTOR inhibitor, and has been effective against renal cell carcinoma, pancreatic neuroendocrine tumors, and advanced kidney tumors, all of which have been unsuccessfully treated with other medications. [MedlinePlus:druginfo/meds/a609032] [NCI:about-cancer/treatment/drugs/fda-everolimus] PMCID: PMC4385860 Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Everolimus
- Part Display Name
- Everolimus
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2007-10-01
- Construct for LOINC Short Name
- Everolimus
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP65523-0 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP65523-0
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| et-EE | Estonian (Estonia) | Everoliimus |
| es-ES | Spanish (Spain) | Everolimus |
| it-IT | Italian (Italy) | Everolimus |
| tr-TR | Turkish (Turkey) | Everolimus |
| ru-RU | Russian (Russian Federation) | Эверолимус |
| nl-NL | Dutch (Netherlands) | everolimus |
| fr-BE | French (Belgium) | Everolimus |
| zh-CN | Chinese (China) | 依维莫司 Synonyms: 40-O-(2-羟乙基)-西罗莫司; |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://